Kaplan, G. G., Ma, C., Seow, C. H., Kroeker, K. I., & Panaccione, R. (2020). The Argument Against a Biosimilar Switch Policy for Infliximab in Patients with Inflammatory Bowel Disease Living in Alberta. J Can Assoc Gastroenterol.

Kaplan, Gilaad G., Christopher Ma, Cynthia H. Seow, Karen I. Kroeker, and Remo Panaccione. "The Argument Against a Biosimilar Switch Policy for Infliximab in Patients With Inflammatory Bowel Disease Living in Alberta." J Can Assoc Gastroenterol 2020.

Kaplan, Gilaad G., et al. "The Argument Against a Biosimilar Switch Policy for Infliximab in Patients With Inflammatory Bowel Disease Living in Alberta." J Can Assoc Gastroenterol 2020.